Oyo Parent Prism Trims Fresh Issue Size to $355 Million as Sagility Clinches $32.35 Million US Acquisition

Indian corporate dealmaking and primary market action saw notable movements as hospitality unicorn Oyo's parent company, Prism, moved to downsize its public listing ambitions, while healthcare services provider Sagility expanded its footprint abroad through targeted inorganic growth.

Oyo Recalibrates Listing Ambitions

Prism, the parent entity of Indian budget hotel network Oyo, has nearly halved the size of its proposed initial public offering (IPO) as it revives efforts to go public. According to recent filings, the SoftBank-backed travel and hospitality platform is now seeking to raise $354.65 million through a fresh issue of equity shares.

The move reflects a measured approach to market realities after multiple deferrals. When Oyo originally filed draft papers for an IPO in 2021, the company had targeted a valuation of up to $12 billion. However, shifting public market sentiment, scrutiny over tech startup profitability, and volatile macroeconomic conditions prompted the company to postpone its debut on several occasions.

Alongside lead backer SoftBank, Oyo’s prominent institutional cap table includes global marquee investors:

• SoftBank
• Airbnb
• Microsoft
• Lightspeed Venture Partners

The reduced issue size is seen as an effort to align offer dynamics with domestic institutional appetite, leaving adequate room on the table for secondary market absorption while focusing capital deployment on balance-sheet optimization and core expansion.

Sagility Inks $32.35 Million US Buyout

In a concurrent development on the cross-border acquisition front, EQT-backed business process management and tech services provider Sagility has entered into a definitive agreement to acquire US-headquartered Chirok Health.

The buyout, valued at $32.35 million, will be executed through the company’s US-based operating subsidiary, Sagility (US) Holdings Inc. Chirok Health specializes in clinical documentation improvement (CDI), medical coding, coding quality assurance, and revenue integrity services tailored for healthcare enterprises.

The acquisition aims to bolster Sagility’s core healthcare provider vertical across several strategic domains:

• Clinical documentation integrity and medical chart review
• Medical coding compliance and quality assurance
• Revenue cycle optimization for institutional healthcare providers

Headquartered in Bengaluru, Sagility delivers technology-enabled services to healthcare payers, providers, and pharmacy benefit managers across key global operations, including the United States, India, Jamaica, Colombia, and the Philippines. The buyout of Chirok Health marks a direct push by the company to deepen high-margin domain specialization and capture recurring enterprise workflows in the North American market.

Tags: Oyo Prism Sagility India SoftBank EQT Indian IPOs